ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
06/27/201615:42:12Statement of Changes in Beneficial Ownership (4)
06/27/201608:00:00Canadian Shopper Study Names Bausch + Lomb Most Trusted Brand...
06/27/201608:00:00Canadian Shopper Study Names Bausch + Lomb Most Trusted Brand...
06/21/201619:49:50Statement of Changes in Beneficial Ownership (4)
06/21/201619:31:17Initial Statement of Beneficial Ownership (3)
06/21/201619:23:54Initial Statement of Beneficial Ownership (3)
06/21/201619:16:38Initial Statement of Beneficial Ownership (3)
06/21/201617:03:52Current Report Filing (8-k)
06/17/201608:00:00Valeant Pharmaceuticals Announces Significant Investments In...
06/17/201608:00:00Valeant Pharmaceuticals Announces Significant Investments In...
06/16/201608:00:00Valeant Pharmaceuticals Announces Launch Of New PreserVision®...
06/16/201608:00:00Valeant Pharmaceuticals Announces Launch Of New PreserVision®...
06/15/201615:49:20Current Report Filing (8-k)
06/15/201608:00:00Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent...
06/15/201608:00:00Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent...
06/13/201617:06:17Statement of Changes in Beneficial Ownership (4)
06/13/201606:49:02Statement of Changes in Beneficial Ownership (4)
06/10/201617:04:18Amended Statement of Beneficial Ownership (sc 13d/a)
06/09/201617:40:00Valeant To Participate In FDA Advisory Committee Meeting On July...
06/09/201617:40:00Valeant To Participate In FDA Advisory Committee Meeting On July...

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad